MIR31HG was also reported to be involved in the progression of multiple cancer, including bladder cancer, pancreatic ductal adenocarcinoma, esophageal squamous cell carcinoma, lung cancer, and et al. [41–43]. This evidence concerns the gene MIR31HG and pancreatic ductal adenocarcinoma.